- Home
- UNB vs GOSS Comparison
UNB vs GOSS Comparison
Compare UNB & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNB
- GOSS
- Stock Information
- Founded
- UNB 1891
- GOSS 2015
- Country
- UNB United States
- GOSS United States
- Employees
- UNB N/A
- GOSS N/A
- Industry
- UNB Major Banks
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- UNB Finance
- GOSS Health Care
- Exchange
- UNB Nasdaq
- GOSS Nasdaq
- Market Cap
- UNB 167.6M
- GOSS 188.6M
- IPO Year
- UNB 1998
- GOSS 2019
- Fundamental
- Price
- UNB $31.34
- GOSS $0.84
- Analyst Decision
- UNB
- GOSS Strong Buy
- Analyst Count
- UNB 0
- GOSS 4
- Target Price
- UNB N/A
- GOSS $7.50
- AVG Volume (30 Days)
- UNB 11.7K
- GOSS 1.5M
- Earning Date
- UNB 05-13-2025
- GOSS 05-06-2025
- Dividend Yield
- UNB 4.63%
- GOSS N/A
- EPS Growth
- UNB N/A
- GOSS N/A
- EPS
- UNB 1.92
- GOSS N/A
- Revenue
- UNB $47,157,000.00
- GOSS $114,701,000.00
- Revenue This Year
- UNB N/A
- GOSS N/A
- Revenue Next Year
- UNB N/A
- GOSS $172.31
- P/E Ratio
- UNB $16.32
- GOSS N/A
- Revenue Growth
- UNB N/A
- GOSS N/A
- 52 Week Low
- UNB $21.00
- GOSS $0.50
- 52 Week High
- UNB $37.70
- GOSS $1.55
- Technical
- Relative Strength Index (RSI)
- UNB 58.70
- GOSS 37.58
- Support Level
- UNB $28.00
- GOSS $0.80
- Resistance Level
- UNB $29.32
- GOSS $0.88
- Average True Range (ATR)
- UNB 1.31
- GOSS 0.10
- MACD
- UNB 0.18
- GOSS -0.01
- Stochastic Oscillator
- UNB 78.91
- GOSS 20.24
About UNB Union Bankshares Inc.
Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The company provides retail banking services to individuals and commercial banking services to small and medium-sized corporations, partnerships, and sole proprietorships, as well as nonprofit organizations, local municipalities, and school districts within its market area. In addition, it also offers fiduciary and asset management services through its Asset Management Group. Geographically, all the business activity is functioned through the United States.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.